Latest News and Press Releases
Want to stay updated on the latest news?
-
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...
-
Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pump Market Industry Trends and Global Forecasts to 2035 - Distribution by Type of Pump (Tethered Pumps and Patch Pumps), Degree of Automation,...
-
embecta will be joined by diabetes advocacy groups to ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November.
-
This unveils the crucial role of a balanced microbiome in boosting immunity, metabolism, & mental clarity. Discover how gut health impacts longevity.
-
Boston, MA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Regenerative Medical Solutions (RMS) is sponsoring the 5th Summit on Stem Cell Derived Islets, which will be held on October 28-29 at the Joseph B....
-
BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes...
-
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the United States: Understanding the Type 2 Diabetes Patient Experience" report has been added to ResearchAndMarkets.com's...
-
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
-
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
-
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.